Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

Completed

Conditions studied: Tobacco Use Disorder, Lung Cancer

In brief

Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 known carcinogens. Biomarkers that quantify carcinogen levels and metabolism are a useful tool and available to use. The purpose of this study is to assess the link between tobacco smoke carcinogen biomarkers and the risk of developing lung cancer.

Key facts

Study ID

NCT00218179

Run by

University of Minnesota

People needed

200

Starts

2005-09-01

Expected to finish

2007-12-01

Last updated by the study team

2017-01-23

Who can join

Age: 55 and older, up to 74. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Screening arm participants in the Prostate, Lung, Colon, and Ovarian Screen Trial (PLCO)
• Reported smoking on baseline questionnaire of PLCO
• Contributed biorepository samples

You may not qualify if…

• Unstable physical or mental health

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.